GEODE CAPITAL MANAGEMENT, LLC - LION BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$3,730,000
+49.7%
500,764
+39.7%
0.00%
+100.0%
Q4 2016$2,491,000
-12.3%
358,466
+3.9%
0.00%0.0%
Q3 2016$2,839,000
+8.4%
344,959
+6.7%
0.00%0.0%
Q2 2016$2,619,000
+61.3%
323,355
+1.1%
0.00%0.0%
Q1 2016$1,624,000
-30.8%
319,759
+5.1%
0.00%0.0%
Q4 2015$2,347,000
+37.9%
304,121
+2.8%
0.00%0.0%
Q3 2015$1,702,000
-30.4%
295,698
+10.8%
0.00%0.0%
Q2 2015$2,447,000266,8800.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 3,187,607$24,608,0008.48%
ACUTA CAPITAL PARTNERS, LLC 1,915,000$14,784,0007.07%
P.A.W. CAPITAL CORP 200,000$1,544,0001.75%
Perceptive Advisors 3,000,161$23,161,0001.71%
NEXTHERA CAPITAL LP 152,266$1,175,0001.67%
Broadfin Capital, LLC 2,105,519$16,255,0001.00%
Trellus Management Company, LLC 60,539$467,0000.69%
Rhenman & Partners Asset Management AB 575,000$4,439,0000.67%
QVT Financial LP 1,433,700$11,068,0000.62%
Cormorant Asset Management, LP 499,815$3,859,0000.46%
View complete list of LION BIOTECHNOLOGIES INC shareholders